Wutah pendapatan kuartal marang kuartal: OraSure (OSUR)

Simbol lan logo merek OraSure Technologies Inc (OSUR)

OraSure Technologies (OSUR) dominates the rapid diagnostics segment thanks to its patents for home tests. The business relies on government contracts and the trend toward molecular saliva analysis. The quarterly revenue trend shows that the parameter value is 14.20. However, post-pandemic product commoditization is eroding margins, forcing the company to implement expensive specialized devices to protect profits.

OraSure Technologies Inc (OSUR) - Wutah pendapatan triwulanan saka 04.07.2022 nganti 20.11.2026

Rincian analitis lan laporan data perusahaan OraSure Technologies Inc (OSUR)

- rega saham lan target rega konsensus:
- indikator kapitalisasi bursa perusahaan:
Analisis umum perusahaan:OraSure Technologies Inc - OSUR
Produk sing diprodhuksi OraSure Technologies, Inc.

For OraSure Technologies (OSUR), which distributes rapid tests through pharmacy chains, quarterly revenue growth serves as an indicator of operational efficiency amid cyclical demand. This metric measures the percentage change in sales volume for the current quarter compared to the same period last year, neutralizing seasonal fluctuations. By analyzing the percentage increase in quarterly sales, an investor assesses the pace of business scaling relative to historical data. Diversified logistics and raw material buffer stocks ensure the stability of this indicator, protecting profitability from external shocks.

Karo sapa OraSure Technologies saingan

A - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Wutah dodolan triwulanan|Wutah dodolan triwulanan Cologuard|RVTY (Revvity Corp) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Bio-Rad Laboratories Inc|Wutah dodolan triwulanan NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal QuidelOrtho Inc. QDEL|Wutah pendapatan triwulanan OPKO Health Inc OPK|CareDx Inc - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan MRVI (Maravai)|FLGT: Wutah pendapatan triwulanan|LAB (Standard BioTools Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Cytek Biosciences Inc|Exagen (XGN) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal MDxHealth, Inc. (MDXH)|Lucid Diagnostics, Inc - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Prenetics PRE|Insight Molecular (IMDX) - Tingkat wutah pendapatan sajrone kuartal|Trinity Biotech Corp - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal ProPhase PRPH|AIMD: Wutah pendapatan triwulanan|CODX - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Heart Test Laboratories, Inc.|Wutah pendapatan kuartal marang kuartal BMRA|Wutah pendapatan triwulanan CDIO|Onconetix - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal viraxbiolabs.com VRAX|Tingkat wutah dodolan sajrone kuartal Bluejay (BJDX)|AWH: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Accelerate Diagnostics, Inc. AXDX|Centogene (CNTG) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ENZ (Enzo)|Wutah dodolan kuartal marang kuartal Fresh2 (FRES)|Genetic Technologies (GENE) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan ME|Wutah pendapatan kuartal marang kuartal PMD (Psychemedics Corporation)